<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03850093</url>
  </required_header>
  <id_info>
    <org_study_id>ZU-IRB 2139-24-5-2015</org_study_id>
    <nct_id>NCT03850093</nct_id>
  </id_info>
  <brief_title>Preoperative Gabapentin Versus Bisoprolol for Hemodynamic Optimization During Sinus Surgery</brief_title>
  <official_title>Preoperative Gabapentin Versus Bisoprolol for Intraoperative Hemodynamic and Surgical Field Optimization During Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      the current study hypothesized that Gabapentin can be effective as Bisoprolol in reduction of
      intraoperative bleeding, improving the operative's field visibility and increase the surgeon
      satisfaction via optimization of blood pressure and heart rate .

      A prospective randomized double blinded controlled study. Eligible patients were randomized
      according to random list generated software and allocated into 3 equal and matched groups (15
      patients in each group):-

        -  Group G: gabapentin group in which Patients were premedicated with oral gabapentin 1200
           mg (Conventin 400mg; Evapharm) with sips of water, 2 hours before induction of
           anesthesia.

        -  Group B: bisoprolol group in which Patients were premedicated with oral bisoprolol 2.5
           mg ( Concor 2.5mg ; Merck/Amoun ) with sips of water, 2 hours before induction of
           anesthesia.

        -  Group C: control group in which Patients were premedicated with oral placebo with sips
           of water, 2 hours before induction of anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis:

      Gabapentin can be effective as Bisoprolol in reduction of intraoperative bleeding, improving
      the operative's field visibility and increase the surgeon satisfaction via optimization of
      blood pressure and heart rate.

      Objectives Compare the effect of preoperative Gabapentin with Bisoprolol on hemodynamics,
      surgical field optimization during endoscopic nasal surgeries.

      Technical design:

      A) Site of study :

      The study was conducted at Anesthesia and Surgical intensive care and Otorhinolaryngology
      departments, faculty of medicine, Zagazig University.

      B) Sample Size :

      According to 80% power of the study, 95% CI and calculated volume of blood loss 200±40 ml and
      150±55ml on Gabapentin (22) and Bisoprolol (15) premedication respectively, the estimated
      Sample size was 54 patients (open EPI) , 63 patients were included in the study to compensate
      for drop out.

      Randomization was carried out on 63 patients to compensate for drop out . All planned ESS
      procedures was managed by the same anesthetist and surgeon who were blinded to the used
      study's premedication. The surgeon was blinded to the monitor recording the hemodynamic
      variables.

      All patients had been preoperatively evaluated according to standard local protocol.
      Preoperative surgical preparation and proper management of infection were confirmed to every
      patient.

      Patient was premedicated by IV ranitidine 50 mg, midazolam 0.05 mg/kg and atropine 20µg/kg
      immediately before admission to the operating room.

      On admission to the operating room, Standard monitoring included 5 leads ECG, non-invasive
      blood pressure, Pulse Oximetry and End-tidal carbon dioxide (ETCO2) trace were applied (B40i
      Monitor - GE Healthcare, Finland).

      Anesthesia was induced with IV propofol 2 mg/kg and fentanyl 1 µg/kg was given for analgesia.
      Cisatracurium 0.15 mg/kg IV was given to facilitate direct laryngoscopy and orotracheal
      intubation. The patient was ventilated at tidal volume 6-8mL/kg and respiratory rate that
      achieved ETCO2 of 30-35 mmHg. Oropharyngeal pack was inserted.

      Anesthesia was maintained by isoflurane based on MAC 1.2 % until a steady state of anesthesia
      was achieved (defined as a state of anesthesia when no changes in hemodynamic variables take
      place for at least 10 min). An increase of ≥ 20% of basal value in both HR and MAP was
      treated with increasing the concentration of isoflurane by 0.5% and increments of fentanyl 1
      μg/kg. Muscle relaxation was confirmed by cisatracurium 0.03mg/kg every 20 mins. IV lactated
      ringer solution was infused at approximately 6ml/kg/hr till the end of the procedure.

      All patients were positioned supine and the bed-head of the surgical table was raised by 30°
      to improve venous drainage.

      Before the beginning of surgical procedure, well wrung out cotton pledgets soaked with 4 ml
      of 2% lignocaine with 1:200,000 adrenaline were topically applied to the nasal mucous
      membrane for 10 min (no infiltration).

      Technique for hemodynamic optimization:

      Target mean arterial pressure (MAP) was 60-70 mmHg during the surgical procedure to achieve
      Fromm and Boezaart category scale of 2 or 3 which is judged to be optimal for surgery (20).

      If the MAP was still ˃70mmHg in spite of increasing isoflurane inhalation to 2.5%,
      nitroglycerine (1-10 μg/kg/min.) titrated to effect.

      If the heart rate was more than 100 beats/ minute, propranolol was titrated 1-3 mg/hour to
      achieve target MAP.

      If mean arterial pressure (MAP) decreased to less than 60 mm Hg, ephedrine in increments of 3
      mg was given.

      Withdrawal vasoactive agents:

      After recording the surgeons' opinion regarding the surgical field and about 15 minutes
      before ending surgery, the infusion of any vasoactive medication (if used) was stopped and
      the anesthetic agent was decreased allowing HR and MAP to return to their basal value. If
      Hypotension (defined as SAP&lt; 90mmHg and bradycardia less than 60 bpm) persisted, they was
      treated by ephedrine in increments of 3 mg .

      On compilation of surgical procedure, anesthesia was discontinued and reversal of
      neuromuscular blockade was achieved using IV neostigmine 0.08 mg/kg and atropine 20µg/kg.
      After removal of oropharyngeal pack, oropharyngeal suction was performed. On the start of
      obeying commands, patients were extubated and shifted to recovery room.

      Patients were discharged to the ward after reaching a score ≥ 9 on the Modified Aldrete
      Scoring System.

      During postoperative period up to 6 hours, the patient was monitored for conscious level,
      oxygen saturation, heart rate and mean arterial blood pressure.

      On ward admission, IM diclofenac sodium 75mg was given then every 12 hours. If the patient
      complained moderate to severe pain (VAS≥ 4) meperidine 25mg increments up to pain relief
      (maximum 100mg as a single dose) was given.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Surgical Field Visibility</measure>
    <time_frame>scale was assessed by the surgeon every 15 minutes from the start of surgical procedure till the end</time_frame>
    <description>according to change in Fromm and Boezaart surgical field category scale ranging from 0 (no bleeding) to 5 (severe bleeding) where: 0 No Bleeding.
Slight bleeding- no blood suctioning required.
Slight bleeding- occasional blood suctioning required.
Slight bleeding- frequent blood suctioning required, operative field is visible for some seconds after evacuation.
Moderate bleeding- frequent blood suctioning required, operative field is only visible immediately after evacuation.
Severe bleeding- constant blood suctioning required, bleeding appears faster than can be removed by suction .Surgery is hardly possible, and sometimes impossible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>at the end of surgery</time_frame>
    <description>total intraoperative blood loss (mL)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Change</measure>
    <time_frame>were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery</time_frame>
    <description>effect of intervention on the change of heart rate allover study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Blood Pressure Change</measure>
    <time_frame>were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery</time_frame>
    <description>effect of intervention on the change of mean arterial blood pressure allover study period</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Surgeon Satisfaction (Categorical)</measure>
    <time_frame>at the end of surgery</time_frame>
    <description>surgeon satisfaction score where given 5 for very satisfied, 4 for satisfied, 3 for neutral, 2 for dissatisfied and 1 for very dissatisfied then number of satisfied (satisfaction score = 5) and disatisfied (satisfaction score less than 5) surgeons was compared between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Patients Who Recieved Intraoperative IV Nitroglycerin During Operative Procedure</measure>
    <time_frame>at the end of surgery</time_frame>
    <description>need for additional intraoperative IV vasodilators (nitroglycerine</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Patients Who Recieved Intraoperative IV Propranolol During Operative Procedure</measure>
    <time_frame>at the end of surgery</time_frame>
    <description>the need for additional beta blockers (propranolol)</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Patients Who Recieve Both IV Nitroglycerin and Propranolol During Operative Procedure</measure>
    <time_frame>at the end of surgery</time_frame>
    <description>need for both IV nitroglycerine and propranolol intraoperatively</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Analogue Scale (VAS) for Postoperative Pain</measure>
    <time_frame>1, 3 and 6 hrs. after recovery</time_frame>
    <description>postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain which was assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Analogue Scale (VAS) for Postoperative Pain</measure>
    <time_frame>0n full recovery, 3 and 6 hrs. after recovery</time_frame>
    <description>postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to 1st Postoperative Rescue Analgesia</measure>
    <time_frame>on administration of 1st postoperative rescue analgesia</time_frame>
    <description>time to 1st postoperative rescue analgesia (starting from administration of the studied drug)</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>gabapentin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bisoprolol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo was given to patients of control group 2 hours preoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin1200 mg</intervention_name>
    <description>patients received 1200mg gabapentin 2 hrs preoperative</description>
    <arm_group_label>gabapentin</arm_group_label>
    <other_name>gaptin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bisoprolol 2.5mg</intervention_name>
    <description>patients received 2.5mg bisoprolol 2 hrs preoperative</description>
    <arm_group_label>bisoprolol</arm_group_label>
    <other_name>concor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>patients received oral placebo 2 hrs preoperative</description>
    <arm_group_label>control</arm_group_label>
    <other_name>vitamins</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who underwent functional endoscopic sinus surgery

          -  ability to swallow tablets

        Exclusion Criteria:

          -  suspected difficult airway

          -  basal HR &lt;60/min.

          -  chronic cardiovascular or cerebrovascular disease

          -  bronchial asthma or COPD

          -  DM

          -  bleeding disorders

          -  anemia (Hb level&lt; 10 gm/dl)

          -  renal or hepatic insufficiency

          -  psychiatric disorders

          -  chronic treatment by BBs, gabapentin or drugs that affect coagulation

          -  acute nasal infection

          -  allergy/contraindications to any of the study's drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abeer M. Elnakera, doctorate</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of medicine - Zagazig university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ayman A. Hassan, doctorate</last_name>
    <role>Study Chair</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maram wagdy, Master</last_name>
    <role>Study Chair</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed W. El-Anwar, doctorate</last_name>
    <role>Study Chair</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>February 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <results_first_submitted>February 22, 2019</results_first_submitted>
  <results_first_submitted_qc>July 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2019</results_first_posted>
  <last_update_submitted>February 1, 2020</last_update_submitted>
  <last_update_submitted_qc>February 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>abeer M. elnakera</investigator_full_name>
    <investigator_title>assistant professor of anesthesia and surgical intensive care</investigator_title>
  </responsible_party>
  <keyword>gabapentin</keyword>
  <keyword>bisoprolol</keyword>
  <keyword>hemodynamic</keyword>
  <keyword>surgical field</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bisoprolol</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>collective data sheet was available to all researchers during and after completing the study. individual patient records are available on request for all researchers</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 15, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03850093/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>66 patients who underwent endoscopic sinus surgery were eligible for the study</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Gabapentin Group (Group G)</title>
          <description>21 patients completed the study and were considered for statistical analysis</description>
        </group>
        <group group_id="P2">
          <title>Bisoprolol Group (Group B)</title>
          <description>22 patients were allocated to group B, completed the study and were considered for statistical analysis</description>
        </group>
        <group group_id="P3">
          <title>Control Group (Group C)</title>
          <description>17 patients completed the study and were considered for statistical analysis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>63 patients were enrolled in the study. after 3 patients' withdrawal, 60 patients completed the study and considered for statistical analysis</population>
      <group_list>
        <group group_id="B1">
          <title>Gabapentin</title>
          <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
        </group>
        <group group_id="B2">
          <title>Bisoprolol</title>
          <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
        </group>
        <group group_id="B3">
          <title>Control</title>
          <description>placebo was given to patients of control group 2 hours preoperative</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="17"/>
            <count group_id="B4" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="7.6"/>
                    <measurement group_id="B2" value="30.5" spread="6.6"/>
                    <measurement group_id="B3" value="28.6" spread="5.1"/>
                    <measurement group_id="B4" value="27.93" spread="6.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>weight, continuous</title>
          <population>patients' withdrawal from the study</population>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87.1" spread="1.1"/>
                    <measurement group_id="B2" value="87.9" spread="11.9"/>
                    <measurement group_id="B3" value="84.5" spread="11.5"/>
                    <measurement group_id="B4" value="85.62" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>indication for surgery, categorical)</title>
          <description>indication for surgery is either due to polyp or sinusitis</description>
          <population>3 patients were withdrawn from the study</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>polyp</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>sinusitis</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>mean arterial blood pressure (MAP), continuous</title>
          <population>3 patients were withdrawn from the study</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96.6" spread="7.5"/>
                    <measurement group_id="B2" value="92.9" spread="7.4"/>
                    <measurement group_id="B3" value="88.2" spread="11.7"/>
                    <measurement group_id="B4" value="93.4" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>heart rate (HR), continuous</title>
          <population>3 patients were withdrawn from the study</population>
          <units>beats/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91.1" spread="11.6"/>
                    <measurement group_id="B2" value="82.9" spread="6.4"/>
                    <measurement group_id="B3" value="83.8" spread="14.8"/>
                    <measurement group_id="B4" value="86.7" spread="11.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>side of surgery</title>
          <description>side of surgery is either bilateral or unilateral</description>
          <population>3 patients were withdrawn from the study</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>bilateral</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>unilateral</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in Surgical Field Visibility</title>
        <description>according to change in Fromm and Boezaart surgical field category scale ranging from 0 (no bleeding) to 5 (severe bleeding) where: 0 No Bleeding.
Slight bleeding- no blood suctioning required.
Slight bleeding- occasional blood suctioning required.
Slight bleeding- frequent blood suctioning required, operative field is visible for some seconds after evacuation.
Moderate bleeding- frequent blood suctioning required, operative field is only visible immediately after evacuation.
Severe bleeding- constant blood suctioning required, bleeding appears faster than can be removed by suction .Surgery is hardly possible, and sometimes impossible.</description>
        <time_frame>scale was assessed by the surgeon every 15 minutes from the start of surgical procedure till the end</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Surgical Field Visibility</title>
          <description>according to change in Fromm and Boezaart surgical field category scale ranging from 0 (no bleeding) to 5 (severe bleeding) where: 0 No Bleeding.
Slight bleeding- no blood suctioning required.
Slight bleeding- occasional blood suctioning required.
Slight bleeding- frequent blood suctioning required, operative field is visible for some seconds after evacuation.
Moderate bleeding- frequent blood suctioning required, operative field is only visible immediately after evacuation.
Severe bleeding- constant blood suctioning required, bleeding appears faster than can be removed by suction .Surgery is hardly possible, and sometimes impossible.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O3" value="4" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O3" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O3" value="2" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>105 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O3" value="2" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Blood Loss</title>
        <description>total intraoperative blood loss (mL)</description>
        <time_frame>at the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Loss</title>
          <description>total intraoperative blood loss (mL)</description>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="10" upper_limit="40"/>
                    <measurement group_id="O2" value="20" lower_limit="10" upper_limit="30"/>
                    <measurement group_id="O3" value="80" lower_limit="30" upper_limit="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate Change</title>
        <description>effect of intervention on the change of heart rate allover study period</description>
        <time_frame>were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate Change</title>
          <description>effect of intervention on the change of heart rate allover study period</description>
          <units>beats/ minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preinduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.6" spread="10.4"/>
                    <measurement group_id="O2" value="73.1" spread="9.5"/>
                    <measurement group_id="O3" value="85.8" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>after induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9" spread="11.8"/>
                    <measurement group_id="O2" value="67.8" spread="6.8"/>
                    <measurement group_id="O3" value="85.9" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 minute after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.3" spread="11.1"/>
                    <measurement group_id="O2" value="73.3" spread="9.4"/>
                    <measurement group_id="O3" value="96.2" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.1" spread="10"/>
                    <measurement group_id="O2" value="70.6" spread="8.8"/>
                    <measurement group_id="O3" value="89.3" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.4" spread="8.6"/>
                    <measurement group_id="O2" value="66.3" spread="5.4"/>
                    <measurement group_id="O3" value="87.8" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.7" spread="8.8"/>
                    <measurement group_id="O2" value="66.6" spread="5.8"/>
                    <measurement group_id="O3" value="90.2" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.4" spread="9.4"/>
                    <measurement group_id="O2" value="67.7" spread="4.9"/>
                    <measurement group_id="O3" value="85.8" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75" spread="7.4"/>
                    <measurement group_id="O2" value="67.1" spread="4.2"/>
                    <measurement group_id="O3" value="80.1" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.3" spread="7.4"/>
                    <measurement group_id="O2" value="66.3" spread="4.8"/>
                    <measurement group_id="O3" value="87.3" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.7" spread="8.9"/>
                    <measurement group_id="O2" value="66" spread="4.3"/>
                    <measurement group_id="O3" value="84.5" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.7" spread="8.4"/>
                    <measurement group_id="O2" value="66.5" spread="3.4"/>
                    <measurement group_id="O3" value="88.1" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>105 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.7" spread="8.1"/>
                    <measurement group_id="O2" value="67.4" spread="5.7"/>
                    <measurement group_id="O3" value="97" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Blood Pressure Change</title>
        <description>effect of intervention on the change of mean arterial blood pressure allover study period</description>
        <time_frame>were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Blood Pressure Change</title>
          <description>effect of intervention on the change of mean arterial blood pressure allover study period</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preinduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.6" spread="6"/>
                    <measurement group_id="O2" value="86.4" spread="6.6"/>
                    <measurement group_id="O3" value="92.4" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>after induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.4" spread="6.9"/>
                    <measurement group_id="O2" value="72.3" spread="9.9"/>
                    <measurement group_id="O3" value="78.2" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 minute after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.6" spread="7.6"/>
                    <measurement group_id="O2" value="76.2" spread="12.9"/>
                    <measurement group_id="O3" value="92.2" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.7" spread="8.4"/>
                    <measurement group_id="O2" value="67.2" spread="7.8"/>
                    <measurement group_id="O3" value="78.6" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.4" spread="7.1"/>
                    <measurement group_id="O2" value="67.7" spread="10.4"/>
                    <measurement group_id="O3" value="76.5" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.4" spread="4.6"/>
                    <measurement group_id="O2" value="70.2" spread="8.8"/>
                    <measurement group_id="O3" value="74" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.4" spread="4.4"/>
                    <measurement group_id="O2" value="66.2" spread="6.8"/>
                    <measurement group_id="O3" value="66.6" spread="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.3" spread="3.4"/>
                    <measurement group_id="O2" value="64.7" spread="6.6"/>
                    <measurement group_id="O3" value="64.6" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9" spread="4.2"/>
                    <measurement group_id="O2" value="66.7" spread="4.8"/>
                    <measurement group_id="O3" value="69.9" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.5" spread="4.4"/>
                    <measurement group_id="O2" value="69.4" spread="8.4"/>
                    <measurement group_id="O3" value="67.7" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" spread="3.5"/>
                    <measurement group_id="O2" value="66.1" spread="4.7"/>
                    <measurement group_id="O3" value="62.7" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>105 minutes after intubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.1" spread="3"/>
                    <measurement group_id="O2" value="67.2" spread="7.7"/>
                    <measurement group_id="O3" value="70" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Surgeon Satisfaction (Categorical)</title>
        <description>surgeon satisfaction score where given 5 for very satisfied, 4 for satisfied, 3 for neutral, 2 for dissatisfied and 1 for very dissatisfied then number of satisfied (satisfaction score = 5) and disatisfied (satisfaction score less than 5) surgeons was compared between groups</description>
        <time_frame>at the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Surgeon Satisfaction (Categorical)</title>
          <description>surgeon satisfaction score where given 5 for very satisfied, 4 for satisfied, 3 for neutral, 2 for dissatisfied and 1 for very dissatisfied then number of satisfied (satisfaction score = 5) and disatisfied (satisfaction score less than 5) surgeons was compared between groups</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>surgeon satisfaction achieved (score≥ 4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>surgeon satisfaction not achieved(score&lt; 4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Patients Who Recieved Intraoperative IV Nitroglycerin During Operative Procedure</title>
        <description>need for additional intraoperative IV vasodilators (nitroglycerine</description>
        <time_frame>at the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Recieved Intraoperative IV Nitroglycerin During Operative Procedure</title>
          <description>need for additional intraoperative IV vasodilators (nitroglycerine</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Patients Who Recieved Intraoperative IV Propranolol During Operative Procedure</title>
        <description>the need for additional beta blockers (propranolol)</description>
        <time_frame>at the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Recieved Intraoperative IV Propranolol During Operative Procedure</title>
          <description>the need for additional beta blockers (propranolol)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Patients Who Recieve Both IV Nitroglycerin and Propranolol During Operative Procedure</title>
        <description>need for both IV nitroglycerine and propranolol intraoperatively</description>
        <time_frame>at the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Recieve Both IV Nitroglycerin and Propranolol During Operative Procedure</title>
          <description>need for both IV nitroglycerine and propranolol intraoperatively</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Visual Analogue Scale (VAS) for Postoperative Pain</title>
        <description>postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain which was assessed</description>
        <time_frame>1, 3 and 6 hrs. after recovery</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Visual Analogue Scale (VAS) for Postoperative Pain</title>
        <description>postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain</description>
        <time_frame>0n full recovery, 3 and 6 hrs. after recovery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analogue Scale (VAS) for Postoperative Pain</title>
          <description>postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>on full recovery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O3" value="5" lower_limit="4" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3hrs. after recovery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O3" value="4" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6hrs after recovery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O3" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Time to 1st Postoperative Rescue Analgesia</title>
        <description>time to 1st postoperative rescue analgesia (starting from administration of the studied drug)</description>
        <time_frame>on administration of 1st postoperative rescue analgesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin</title>
            <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
          </group>
          <group group_id="O2">
            <title>Bisoprolol</title>
            <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>placebo was given to patients of control group 2 hours preoperative</description>
          </group>
        </group_list>
        <measure>
          <title>Time to 1st Postoperative Rescue Analgesia</title>
          <description>time to 1st postoperative rescue analgesia (starting from administration of the studied drug)</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="0" upper_limit="90"/>
                    <measurement group_id="O2" value="30" lower_limit="20" upper_limit="50"/>
                    <measurement group_id="O3" value="20" lower_limit="0" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>intra-operative and up to 6 hours postoperative</time_frame>
      <desc>hypertension:MAP elevation by more than 20% from baseline value hypotension : systolic arterial pressure (SAP) less than 90 mmHg tachycardia : HR more than 90 beats/min bradycardia: HR less than 60 beats/min incidence of nausea and vomiting</desc>
      <group_list>
        <group group_id="E1">
          <title>Gabapentin</title>
          <description>gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative</description>
        </group>
        <group group_id="E2">
          <title>Bisoprolol</title>
          <description>bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative</description>
        </group>
        <group group_id="E3">
          <title>Control</title>
          <description>placebo was given to patients of control group 2 hours preoperative</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>hypotension</sub_title>
                <description>SAP less than 90 mmHg</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>bradycardia</sub_title>
                <description>HR less than 60 beats/min</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>hypertension</sub_title>
                <description>MAP elevation by more than 20% from baseline</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="20" subjects_affected="10" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>tachycardia</sub_title>
                <description>HR more than 90 beats/min</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="18" subjects_affected="9" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>postoperative nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E3" events="10" subjects_affected="5" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>postoperative vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>agitation on recovery</sub_title>
                <description>Richmond Agitation Sedation Scale (RASS) equal +2</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small sample size, short study period (until 6 hrs. postoperatively) and unavailability of BIS index monitoring.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>assistant professor Abeer M. Elnakera</name_or_title>
      <organization>faculty of medicine- Zagazig university</organization>
      <phone>00201005720754</phone>
      <email>nakera35@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

